MCK
McKesson CorporationNYSEHealthcare$884.28+1.37%OpenMarket Cap: $109.14B
As of 2026-04-06
Valuation
P/E (TTM)
25.15
PEG
0.47
P/B
-83.93
P/S
0.27
EV/EBITDA
17.75
DCF Value
$607.39
FCF Yield
9.3%
Div Yield
0.4%
Margins & Returns
Gross Margin
3.4%
Operating Margin
1.3%
Net Margin
1.1%
ROE
-245.3%
ROA
6.3%
ROIC
24.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2026 | $106.16B | 3.5% | $1.62B | $1.19B | $9.59 | $0.82 |
| Q2 2026 | $103.15B | 3.4% | $1.47B | $1.11B | $8.92 | $0.82 |
| Q1 2026 | $97.83B | 3.4% | $1.04B | $784.0M | $6.25 | $0.71 |
| Q4 2025 | $90.82B | 3.2% | $1.04B | $1.26B | $10.01 | $0.71 |
| FY 2025 | $359.05B | 3.5% | $4.37B | $3.29B | $25.72 | $2.75 |
| Q3 2025 | $95.29B | 3.4% | $1.29B | $879.0M | $6.94 | $0.71 |
| Q2 2025 | $93.65B | 3.4% | $745.0M | $241.0M | $1.86 | $0.71 |
| Q1 2025 | $79.28B | 3.7% | $1.06B | $915.0M | $7.00 | $0.62 |
| Q4 2024 | $76.36B | 4.5% | $1.37B | $791.0M | $6.01 | $0.62 |
| FY 2024 | $308.95B | 3.9% | $3.93B | $3.00B | $22.39 | $2.40 |
| Q3 2024 | $80.90B | 3.7% | $623.0M | $589.0M | $4.42 | $0.62 |
| Q2 2024 | $77.22B | 3.8% | $898.0M | $664.0M | $4.93 | $0.62 |